Skip to main content
Figure 5 | BMC Cardiovascular Disorders

Figure 5

From: Funnel plots, performance variation and the Myocardial Infarction National Audit Project 2003–2004

Figure 5

Funnel plot for percentage of patients receiving a HMG-CoA reductase inhibitor as secondary prevention medication on discharge from hospital. Data abstracted from the MINAP Third Public Report.[11] Statin = HMG-CoA reductase inhibitor, LCL = lower control limit, UCL = upper control limit, target = National Service Framework for coronary heart disease goal of 80%, target 25% = more than 25% from the goal.

Back to article page